731 related articles for article (PubMed ID: 26642243)
41. Association of Clinical Phenotypes in Haploinsufficiency A20 (HA20) With Disrupted Domains of A20.
Chen Y; Ye Z; Chen L; Qin T; Seidler U; Tian D; Xiao F
Front Immunol; 2020; 11():574992. PubMed ID: 33101300
[No Abstract] [Full Text] [Related]
42. Context-dependent cooperation between nuclear factor κB (NF-κB) and the glucocorticoid receptor at a TNFAIP3 intronic enhancer: a mechanism to maintain negative feedback control of inflammation.
Altonsy MO; Sasse SK; Phang TL; Gerber AN
J Biol Chem; 2014 Mar; 289(12):8231-9. PubMed ID: 24500711
[TBL] [Abstract][Full Text] [Related]
43. A20 inhibits LUBAC-mediated NF-κB activation by binding linear polyubiquitin chains via its zinc finger 7.
Verhelst K; Carpentier I; Kreike M; Meloni L; Verstrepen L; Kensche T; Dikic I; Beyaert R
EMBO J; 2012 Oct; 31(19):3845-55. PubMed ID: 23032186
[TBL] [Abstract][Full Text] [Related]
44. Structure of the A20 OTU domain and mechanistic insights into deubiquitination.
Komander D; Barford D
Biochem J; 2008 Jan; 409(1):77-85. PubMed ID: 17961127
[TBL] [Abstract][Full Text] [Related]
45. Nuclear factor-kappaB regulates beta-cell death: a critical role for A20 in beta-cell protection.
Liuwantara D; Elliot M; Smith MW; Yam AO; Walters SN; Marino E; McShea A; Grey ST
Diabetes; 2006 Sep; 55(9):2491-501. PubMed ID: 16936197
[TBL] [Abstract][Full Text] [Related]
46. Characteristics of CARMA1-BCL10-MALT1-A20-NF-κB expression in T cell-acute lymphocytic leukemia.
Ma Y; Liao Z; Xu Y; Zhong Z; Wang X; Zhang F; Chen S; Yang L; Luo G; Huang X; Huang S; Wu X; Li Y
Eur J Med Res; 2014 Nov; 19(1):62. PubMed ID: 25384343
[TBL] [Abstract][Full Text] [Related]
47. The seventh zinc finger motif of A20 is required for the suppression of TNF-α-induced apoptosis.
Yamaguchi N; Yamaguchi N
FEBS Lett; 2015 May; 589(12):1369-75. PubMed ID: 25911380
[TBL] [Abstract][Full Text] [Related]
48. Open reading frame 3 of genotype 1 hepatitis E virus inhibits nuclear factor-κappa B signaling induced by tumor necrosis factor-α in human A549 lung epithelial cells.
Xu J; Wu F; Tian D; Wang J; Zheng Z; Xia N
PLoS One; 2014; 9(6):e100787. PubMed ID: 24959724
[TBL] [Abstract][Full Text] [Related]
49. Expression, biological activities and mechanisms of action of A20 (TNFAIP3).
Verstrepen L; Verhelst K; van Loo G; Carpentier I; Ley SC; Beyaert R
Biochem Pharmacol; 2010 Dec; 80(12):2009-20. PubMed ID: 20599425
[TBL] [Abstract][Full Text] [Related]
50. Expression of the nuclear factor-κB inhibitor A20 is altered in the cystic fibrosis epithelium.
Kelly C; Williams MT; Mitchell K; Elborn JS; Ennis M; Schock BC
Eur Respir J; 2013 Jun; 41(6):1315-23. PubMed ID: 23018911
[TBL] [Abstract][Full Text] [Related]
51. Identification of the NF-κB inhibitor A20 as a key regulator for human adipogenesis.
Dorronsoro A; Lang V; Jakobsson E; Ferrin I; Salcedo JM; Fernández-Rueda J; Fechter K; Rodriguez MS; Trigueros C
Cell Death Dis; 2013 Dec; 4(12):e972. PubMed ID: 24357803
[TBL] [Abstract][Full Text] [Related]
52. IkappaB kinase beta phosphorylates the K63 deubiquitinase A20 to cause feedback inhibition of the NF-kappaB pathway.
Hutti JE; Turk BE; Asara JM; Ma A; Cantley LC; Abbott DW
Mol Cell Biol; 2007 Nov; 27(21):7451-61. PubMed ID: 17709380
[TBL] [Abstract][Full Text] [Related]
53. Adenovirus-mediated expression of a dominant negative mutant of p65/RelA inhibits proinflammatory gene expression in endothelial cells without sensitizing to apoptosis.
Soares MP; Muniappan A; Kaczmarek E; Koziak K; Wrighton CJ; Steinhäuslin F; Ferran C; Winkler H; Bach FH; Anrather J
J Immunol; 1998 Nov; 161(9):4572-82. PubMed ID: 9794384
[TBL] [Abstract][Full Text] [Related]
54. Haploinsufficiency of A20 and other paediatric inflammatory disorders with mucosal involvement.
Aeschlimann FA; Laxer RM
Curr Opin Rheumatol; 2018 Sep; 30(5):506-513. PubMed ID: 29916847
[TBL] [Abstract][Full Text] [Related]
55. Cystic Fibrosis from Laboratory to Bedside: The Role of A20 in NF-κB-Mediated Inflammation.
Bannon A; Zhang SD; Schock BC; Ennis M
Med Princ Pract; 2015; 24(4):301-10. PubMed ID: 25925366
[TBL] [Abstract][Full Text] [Related]
56. Nodakenin suppresses lipopolysaccharide-induced inflammatory responses in macrophage cells by inhibiting tumor necrosis factor receptor-associated factor 6 and nuclear factor-κB pathways and protects mice from lethal endotoxin shock.
Rim HK; Cho W; Sung SH; Lee KT
J Pharmacol Exp Ther; 2012 Sep; 342(3):654-64. PubMed ID: 22637723
[TBL] [Abstract][Full Text] [Related]
57. A20: linking a complex regulator of ubiquitylation to immunity and human disease.
Ma A; Malynn BA
Nat Rev Immunol; 2012 Nov; 12(11):774-85. PubMed ID: 23059429
[TBL] [Abstract][Full Text] [Related]
58. A20 inhibits human salivary adenoid cystic carcinoma cells invasion via blocking nuclear factor-kappaB activation.
Zhang B; Guan CC; Chen WT; Zhang P; Yan M; Shi JH; Qin CL; Yang Q
Chin Med J (Engl); 2007 Oct; 120(20):1830-5. PubMed ID: 18028781
[TBL] [Abstract][Full Text] [Related]
59. Haploinsufficiency of A20 (HA20): updates on the genetics, phenotype, pathogenesis and treatment.
Yu MP; Xu XS; Zhou Q; Deuitch N; Lu MP
World J Pediatr; 2020 Dec; 16(6):575-584. PubMed ID: 31587140
[TBL] [Abstract][Full Text] [Related]
60. A20 Haploinsufficiency in a Chinese Patient With Intestinal Behcet's Disease-Like Symptoms: A Case Report.
Chen Y; Huang H; He Y; Chen M; Seidler U; Tian D; Xiao F
Front Immunol; 2020; 11():1414. PubMed ID: 32719680
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
